Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy

The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study

(2020) Xue‐Song Sun et al.   Cancer Communications

Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma

(2019) Jingfeng Zong et al.   Radiation Oncology

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

(2018) Anthony T.C. Chan et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

(2018) K.H. Au et al.   ORAL ONCOLOGY

Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma

(2018) Yu-Hung Chen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma

(2018) Shao-Bo Liang et al.   RADIOTHERAPY AND ONCOLOGY

Local regression and control of T1-2 nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

(2018) Fen Xue et al.   Cancer Medicine

Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center

(2017) Li-Rong Wu et al.   ORAL ONCOLOGY

Magnetic Resonance Imaging–Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy

(2017) Caineng Cao et al.   Cancer Research and Treatment

Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma

(2017) Jia-Wei Lv et al.   Journal of Cancer

Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: An analysis of survival and treatment toxicities

(2015) Cai-neng Cao et al.   ORAL ONCOLOGY

A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma

(2015) Yuxiang He et al.   Radiation Oncology

Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy

(2015) Cai-neng Cao et al.   PLoS One

Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study

(2014) Ning Zhang et al.   BMC CANCER

Current Treatment Options for Local Residual Nasopharyngeal Carcinoma

(2013) S. D. Stoker et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma

(2013) Feng Liu et al.   Radiation Oncology

Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma

(2013) J.L.-Y. Chen et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma

(2012) Cai-neng Cao et al.   ORAL ONCOLOGY

Stereotactic radiotherapy-an approach to improve localcontrol of nasopharyngeal carcinoma

(2012) Jian-Ping Xiao et al.   Chinese Journal of Cancer

Intensity-Modulated Radiation Therapy in the Salvage of Locally Recurrent Nasopharyngeal Carcinoma

(2011) Sufang Qiu et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation Therapy

(2011) C. Chen et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY